Recurrent angiotensin-converting enzyme inhibitor-associated angioedema

JAMA

Volumn 278, Issue 3, 1997, Pages 232-233

  Brown, Nancy J ^a,b,c   Snowden, Mary ^a   Griffin, Marie R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; ARTICLE; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG LABELING; DRUG SAFETY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 0030806877     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.3.232     Document Type: Article

References (4)

1. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor associated angioedema. Clin Pharmacol Ther. 1996;60:8-13.
2. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
3. Rothman KJ. Modern Epidemiology. Boston, Mass: Little Brown & Co Inc; 1986:153-156.
4. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med. 1992;117: 234-242.